2nd Quarter - Report

VENABLE LLP for AMPHASTAR PHARMACEUTICALS INC.

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Guidance on drug approval process and filings with the FDA.

LobbyistCovered position, as disclosed
BART STUPAK —

Contacted: SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.